The isatin sulfonamide derivatives showed an ability to depress the action of the survival mechanism of Bcl-2, inhibiting angiogenesis, and further hindering cancer invasion through inhibition of uPA and heparanase expression. This evidence concerns the gene PLAU and cancer.